|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.31 CHF | -0.64% |
|
-2.00% | -5.10% |
| Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Santhera Pharmaceuticals Holding AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CHF 3.45 million compared to negative sales of CHF 3.72 million a year ago. Revenue was CHF 103.38 million compared to CHF 7.47 million a year ago.
Net income was CHF 54.78 million compared to net loss of CHF 71.08 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.10% | 94.83M | |
| +5.48% | 71.19B | |
| +12.55% | 9.3B | |
| -13.75% | 5.01B | |
| +42.38% | 4.47B | |
| +4.51% | 3.96B | |
| -19.05% | 2.41B | |
| -28.72% | 2.23B | |
| +11.13% | 2.02B | |
| +6.53% | 1.69B |
SANTHERA PHARMACEUTICALS HOLDING AG 
